Curis, Inc. ("Curis") (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, yesterday presented data ...
India’s liquor regulations have been complex for long. But GST and states’ need to shore up revenue is beginning to change ...
Asia stocks followed Wall Street futures lower on Monday as investors struggled to price in the risk of imminent U.S. tariffs ...
Traders nervously awaited “Liberation Day” on Wednesday, April 2, when the Trump administration’s tariffs are scheduled to go ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback